GenMark Diagnostics (GNMK) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
GenMark Diagnostics (GNMK) Halted on LUDP
November 3, 2017 9:54 AM EDTGenMark Diagnostics (NASDAQ: GNMK) Halted on LUDP
... MoreGenMark Diagnostics (GNMK) PT Lowered to $10 at Cowen Following 3Q Miss
November 3, 2017 8:15 AM EDTCowen lowered its price target on GenMark Diagnostics (NASDAQ: GNMK) to $10.00 (from $17.00) while maintaining a Outperform rating following the company's 3Q. Revenue of $11.6MM was $3MM below consensus.
Management reduced full year revenue guidance to $51-53MM from $65-70MM. Management attributed the... More
